Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


16.10.2017

1 Am J Clin Pathol
1 Am J Epidemiol
3 Ann Thorac Surg
2 Br J Cancer
3 Cancer
3 Cancer Lett
1 Chest
1 Clin Lung Cancer
2 Eur J Cancer
3 Int J Cancer
3 J Clin Invest
2 J Clin Oncol
2 J Thorac Cardiovasc Surg
3 J Thorac Oncol
2 Lancet Oncol
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. JEFFUS SK, Gardner JM, Steliga MA, Shah AA, et al
    Hyalinizing Clear Cell Carcinoma of the Lung: Case Report and Review of the Literature.
    Am J Clin Pathol. 2017;148:73-80.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  2. LUQUE-FERNANDEZ MA, Belot A, Valeri L, Ceruli G, et al
    Data-Adaptive Estimation for Double-Robust Methods in Population-Based Cancer Epidemiology: Risk differences for lung cancer mortality by emergency presentation.
    Am J Epidemiol. 2017 Sep 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. CATTONI M, Vallieres E, Brown LM, Sarkeshik AA, et al
    External Validation of a Prognostic Model of Survival for Resected Typical Bronchial Carcinoids.
    Ann Thorac Surg. 2017;104:1215-1220.
    PubMed     Text format     Abstract available

  4. ANDERSON KL JR, Mulvihill MS, Speicher PJ, Yerokun BA, et al
    Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.
    Ann Thorac Surg. 2017;104:1221-1230.
    PubMed     Text format     Abstract available

  5. GUERRERA F, Renaud S, Schaeffer M, Nigra V, et al
    Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.
    Ann Thorac Surg. 2017 Jul 28. pii: S0003-4975(17)30671.
    PubMed     Text format     Abstract available


    Br J Cancer

  6. VAHL JM, Friedrich J, Mittler S, Trump S, et al
    Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.
    Br J Cancer. 2017 Oct 10. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  7. NI Z, Yao C, Zhu X, Gong C, et al
    Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1.
    Br J Cancer. 2017 Oct 12. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  8. HEYMANN JJ, Bulman WA, Swinarski D, Pagan CA, et al
    Programmed death-ligand 1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
    Cancer. 2017 Oct 12. doi: 10.1002/cncy.21937.
    PubMed     Text format     Abstract available

  9. SULLIVAN DR, Ganzini L, Lapidus JA, Hansen L, et al
    Improvements in hospice utilization among patients with advanced-stage lung cancer in an integrated health care system.
    Cancer. 2017 Oct 10. doi: 10.1002/cncr.31047.
    PubMed     Text format     Abstract available

  10. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Text format     Abstract available


    Cancer Lett

  11. YANG H, Lee MH, Park I, Jeon H, et al
    HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
    Cancer Lett. 2017;411:19-26.
    PubMed     Text format     Abstract available

  12. TORRES-DURAN M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, et al
    Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30603.
    PubMed     Text format     Abstract available

  13. TANG ZH, Cao WX, Guo X, Dai XY, et al
    Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30624.
    PubMed     Text format     Abstract available


    Chest

  14. CHADDHA U, Puscas I, Prosper A, Ganesh S, et al
    A 63-Year-Old Woman With Neurofibromatosis Type 1 and Pulmonary Hypertension With Worsening Hypoxemia.
    Chest. 2017;152:e89-e93.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  15. MA L, Ye W, Li Q, Wang B, et al
    Subjective Global Assessment (SGA) Score Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients With Normal Pulmonary Function Treated by Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy.
    Clin Lung Cancer. 2017 Sep 19. pii: S1525-7304(17)30259.
    PubMed     Text format     Abstract available


    Eur J Cancer

  16. DE LA PENA H, Sharma A, Glicksman C, Joseph J, et al
    No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.
    Eur J Cancer. 2017;84:354-359.
    PubMed     Text format     Abstract available

  17. SORIA JC, Adjei AA, Bahleda R, Besse B, et al
    A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced n
    Eur J Cancer. 2017;86:186-196.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. LIU HX, Tao LL, Zhang J, Zhu YG, et al
    Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31098.
    PubMed     Text format     Abstract available

  19. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    PubMed     Text format     Abstract available

  20. DIETZ S, Harms A, Endris V, Eichhorn F, et al
    Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.
    Int J Cancer. 2017;141:1841-1848.
    PubMed     Text format     Abstract available


    J Clin Invest

  21. WANG YT, Chen J, Chang CW, Jen J, et al
    Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment.
    J Clin Invest. 2017;127:2982-2997.
    PubMed     Text format     Abstract available

  22. JESCHKE J, Bizet M, Desmedt C, Calonne E, et al
    DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
    J Clin Invest. 2017;127:3090-3102.
    PubMed     Text format     Abstract available

  23. AYERS M, Lunceford J, Nebozhyn M, Murphy E, et al
    IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade.
    J Clin Invest. 2017;127:2930-2940.
    PubMed     Text format     Abstract available


    J Clin Oncol

  24. SMIT EF, Haanen JBAG
    Pembrolizumab in Small-Cell Lung Cancer: In Search of the Best Biomarker.
    J Clin Oncol. 2017 Oct 10:JCO2017745141. doi: 10.1200/JCO.2017.74.5141.
    PubMed     Text format    

  25. HORN L, Spigel DR, Vokes EE, Holgado E, et al
    Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
    J Clin Oncol. 2017 Oct 12:JCO2017743062. doi: 10.1200/JCO.2017.74.3062.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  26. ANTONOFF MB
    Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?
    J Thorac Cardiovasc Surg. 2017 Sep 8. pii: S0022-5223(17)31866.
    PubMed     Text format    

  27. GILBERT CR, Ely R, Fathi JT, Louie BE, et al
    The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
    J Thorac Cardiovasc Surg. 2017 Sep 13. pii: S0022-5223(17)31890.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  28. TOKACA N, Barth S, O'Brien M, Bhosle J, et al
    Molecular adequacy of image-guided rebiopsies for molecular retesting in advanced non-small cell lung cancer: a single centre experience.
    J Thorac Oncol. 2017 Oct 5. pii: S1556-0864(17)32760.
    PubMed     Text format     Abstract available

  29. THAKUR MK, Ruterbusch JJ, Schwartz AG, Gadgeel SM, et al
    Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology and End Results (SEER) Data.
    J Thorac Oncol. 2017 Oct 5. pii: S1556-0864(17)32766.
    PubMed     Text format     Abstract available

  30. SHUKUYA T, Patel S, Shane-Carson K, He K, et al
    Lung Cancer Patients with Germline Mutations detected by next generation sequencing and/or liquid biopsy.
    J Thorac Oncol. 2017 Oct 5. pii: S1556-0864(17)32764.
    PubMed     Text format    


    Lancet Oncol

  31. PAVEL ME, Singh S, Strosberg JR, Bubuteishvili-Pacaud L, et al
    Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase
    Lancet Oncol. 2017;18:1411-1422.
    PubMed     Text format     Abstract available

  32. VAN ZANDWIJK N, Pavlakis N, Kao SC, Linton A, et al
    Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
    Lancet Oncol. 2017;18:1386-1396.
    PubMed     Text format     Abstract available


    PLoS One

  33. KASPI E, Frankel D, Guinde J, Perrin S, et al
    Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.
    PLoS One. 2017;12:e0183136.
    PubMed     Text format     Abstract available

  34. KROSNICK JA, Malhotra N, Mo CH, Bruera EF, et al
    Perceptions of health risks of cigarette smoking: A new measure reveals widespread misunderstanding.
    PLoS One. 2017;12:e0182063.
    PubMed     Text format     Abstract available

  35. TUDOR RA, D'Silva A, Tremblay A, MacEachern P, et al
    Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.
    PLoS One. 2017;12:e0181867.
    PubMed     Text format     Abstract available

  36. JIN C, Zhang G, Zhang Y, Hua P, et al
    Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells.
    PLoS One. 2017;12:e0181731.
    PubMed     Text format     Abstract available

  37. YU PY, Gardner HL, Roberts R, Cam H, et al
    Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    PLoS One. 2017;12:e0181885.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: